RESUMO
Background: occult hepatitis B viral infection is the presence of hepatitis B viral nucleic acids in the serum and/or liver in the absence of hepatitis B surface antigen
Aim: the study aimed to determine the prevalence of occult hepatitis B virus infection among hepatitis C virus-negative hemodialysis patients and to identify their genotypes
Methods: of 144 patients on maintenance hemodialysis, 50 hepatitis B surface antigen and hepatitis C virus nucleic acid-negative patients were selected according to strict inclusion criteria to avoid the effect of confounding variables. The following investigations were done: serum AST and ALT; HBsAg; HBcAb; HCV-Ab; HCV-RNA; and HBV-DNA
Results: positive hepatitis B viral nucleic acid was confirmed in 12/144 [8.3%] hemodialysis patients and 12/50 [24%] in our study group [occult infection]. Mean hemodialysis periods for negative patients and occult hepatitis B virus patients were 27.3 +/- 18.8 and 38.4 +/- 8.14 months, respectively, and this difference was significant [p-value = 0.02]. Mean alanine transaminase levels were 20.27 +/- 5.5 IU/L and 25.3 +/- 9.6 in negative patients and occult infection patients, respectively. This difference was non-significant. Aspartate transaminase levels were 21.4 +/- 10.2 IU/L and 27.3 +/- 4.6 IU/L, respectively, in negative patients and infected patients; this difference was significant [p-value = 0.03]. Half [6/12] of the positive samples belonged to genotype 'B', 33.3% [4/12] to 'C', and 16.6% [2/12] to genotype 'D'
Conclusion: OBI is likely among hemodialysis patients even without HCV coinfection [24%]. Genotype D cannot be the only genotype distributed in Upper Egypt, as the current study reported relatively new results that 50% of the patients with occult B carry genotype B, 33.3% carry genotype C and only 16.6% carry genotype D